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The Editorial Board of the Annals of Surgical
Oncology decided during the last year to develop a
speciﬁc section of the Journal featuring studies that
highlight the importance of well-done outcomes re-
search pertinent to both the short- and long-term
term surgical treatment of cancer. As editor of this
section, it is particularly satisfying for me and the
entire Editorial Board to include the work of Wouters
and colleagues from the Netherlands Cancer Insti-
tute
1 in this months publication. It is also rewarding
for me to write a companion piece relating to this
article since these authors conﬁrm my particular
biases,
2 which include the concept that surgical case
volume alone is not the only predictor of good out-
come in the management of surgical treatment of
cancer.
Wouters et al. have performed an in-depth study of
the short- and long-term outcomes following resec-
tion for esophageal cancer both in low-volume and
high-volume hospitals associated with the Compre-
hensive Cancer Center in Leiden. They have com-
pared patients managed in 11 low-volume (<7
resections per year) hospitals to patients managed in
a single high-volume center in Leiden. As previous
studies have shown
3,4 dealing with both esophageal
and pancreatic cancer, the mortality and morbidity
rates were signiﬁcantly lower in the high-volume
center. The authors, however, did not curtail their
analysis at that point. They further initiated an
investigation of the individual patient comorbidities
at the respective hospitals and showed that comor-
bidity was indeed a strong prognostic factor in pre-
dicting in-hospital mortality. This fact of course is
not surprising, but the analysis of the case-mix data is
frequently omitted from studies that look at volume
as a singular predictor of quality. Furthermore, the
authors analyzed the penultimate outcome in cancer
management—5-year survival—and showed that at
least for early-stage esophageal cancer (Stages I and
II) there was a signiﬁcantly better 5-year survival in
the high-volume center.
This study once again conﬁrms that the entire
hospital environment is the most important predictor
of patient outcome and that volume is but one indi-
cator of quality in this equation. It is interesting that
the authors made no mention of individual surgeon
volume and performance, but related their outcomes
to the total number of patients managed in the hos-
pital environment. We are not told how many sur-
geons were involved in the 342 operations performed
in the low-volume hospitals or in the 561 procedures
performed in the high-volume centers. While this
would be interesting, the important issues are overall
care and the institutional infrastructure related to the
management of cancer, not the case volume charac-
teristics of the individual surgeons. It is assumed that
even surgeons with a lower volume can have excellent
results when they operate in an environment dedi-
cated to good surgical support and cancer care.
It is obvious that in the discussion of any speciﬁc
cancer, the outcome of the cancer patient relating to
stage is an important characteristic. Wouters and
colleagues looked not only at hospital volume, but
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14also at patient, tumor, and treatment characteristics.
Relating to esophageal management in the high-vol-
ume center, most patients were treated with transhi-
atal techniques with associated cervical anastomoses,
while transthoracic procedures involving anastomo-
ses in the chest were performed in low-volume cen-
ters. Obviously, choice of procedure is an important
issue and morbidity resulting from varying tech-
niques must be taken into account in any outcome
study relating to volume. It was a little surprising,
however, to see that positive margins of resection
were actually higher in the high-volume centers. Since
our mission as oncologic surgeons is to achieve R0
resections, certainly a benchmark of quality should
be a high incidence of complete pathologic resection
in any cancer operation. Perhaps the transhiatal ap-
proach contributed to the lower incidence of R0
resections in the high-volume centers. This fact,
however, apparently did not aﬀect the outcome
especially in early-stage patients in centers with
higher volumes.
There is no question that cancers of the pancreas,
esophagus, and liver have been shown to have better
outcomes when managed by surgeons with extensive
experience in treating these lesions.
3–5 Probably the
most important indicator, however, as supported by
the Dutch group, is that institutional volume plays a
signiﬁcant role in ensuring better patient outcomes in
certain malignancies. The authors further tell us that
dependence on large administrative databases for the
purpose of assessing quality is fraught with danger.
An example of this is a recent publication
6 relating to
increased mortality rates after lumpectomy in the
treatment of breast cancer in ‘‘low-volume’’ hospitals.
This study sends the wrong message and can ad-
versely affect good surgeons who work in small- and
medium-sized community hospitals.
Case volume has also surfaced as an important
prognostic factor in the surgical management of be-
nign abnormalities such as coronary artery disease
and aortic aneurysms. It is hard to refute the notion
that patients cared for by high-volume surgeons and
high-volume institutions will inherently have better
short-term and long-term outcomes. Although vol-
ume may be a structural measure of quality and
‘‘in-house’’ mortality may be an outcome measure,
there continues to be a variable relationship between
volume and outcome. There is no question that high-
volume surgeons may indeed have poor outcomes.
Quality standards relating to the entire institution are
thus much more appropriate to have in place. The
concept of risk adjustment must always be considered
since this reduces the size of the volume eﬀect be-
tween ‘‘low-’’ and ‘‘high-’’ volume hospitals and
surgeons. This case mix may reﬂect the diﬀerences in
socioeconomic levels of patients and the initial stage
of cancers in populations treated by a given hospital
and its surgical staﬀ.
In my opinion, the paper by Wouters and col-
leagues should be used as a benchmark of solid out-
comes research since it includes important indicators
other than volume alone. Careful analysis of indi-
vidual patients and their comorbidities is needed in
these research models. The ultimate challenge for
Wouters and his colleagues working in Holland is to
export the excellence achieved in the Comprehensive
Cancer Center and the speciﬁc high-volume hospital
to all of the other eleven hospitals working in the
aﬃliated system. I particularly look forward to the
day when these researchers can tell me they have
identiﬁed the benchmarks and have successfully
transmitted these concepts to allow every patient with
esophageal cancer to be managed equally in hospitals
under their aegis!
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